Pharma firm Panacea Biotec today reported net loss of 62.28 crore for the third quarter ended December 31, 2012.

The company had posted a net loss of Rs 71.72 crore for the corresponding period previous fiscal.

Net sales of the company rose to Rs 166.28 crore for the quarter under consideration from Rs 152.98 crore for the same period year ago, Panacea Biotec said in a filing to the BSE.

“The company has got orders from the Government of India for supply of Trivalent Oral Polio Vaccines and Bivalent Oral Polio Vaccines worth Rs 187.61 crore to be supplied during the period December 2012 till May 2013 to meet the requirements of National Immunisation Days and Supplementary National Immunisation Days,” Panacea Biotec said.

Shares of Panacea Biotec today closed at Rs 129.25 apiece on the BSE, down 2.49 per cent from their previous close.

(This article was published on February 8, 2013)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.